Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned sub...
Singapore: The 17th edition of BioJapan is all set to kick off from October 14, 2015 Pacifico Yokohama. Top industry pla...
Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the t...
Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end ...
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...
Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in t...
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...
Singapore: Japan's Patent Office has granted a key patent to drug and diagnostic company Agenix covering the manufacturi...
Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...
Singapore: Scil Proteins, a private biotech company specializing in the research, development and production of recombin...
Singapore: Takeda Pharmaceutical Company acquired URL Pharma through its wholly-owned subsidiary Takeda America Holdings...
Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory C...
The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US...
The world's largest biotechnology company Amgen entered into a long-term collaboration with Astellas Pharma in May this ...
